How Gilead Sciences, Inc. stacks up

GILD · against 20 other Healthcare companies of similar size

Overall

18/ 100

Near the bottom of its peers.

Ranked #21 of 21 · scores higher than 0% of peers

Bars: peers in each 10-point band of the overall score

1 peers with an overall score of 10–19, including GILD · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#21 of 21Score 8 / 100 · beats 0%Growth#18 of 21Score 26 / 100 · beats 10%Profitability#21 of 21Score 30 / 100 · beats 0%Risk#19 of 21Higher relative risk · safety 9 · beats 10%

Ranking by overall score

Top 5 and the companies ranked around GILD

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Novo Nordisk A/SNVO · US-listed	177.5B USD	71	92	60	99	2 / 2
2	Vertex Pharmaceuticals IncorporatedVRTX · US-listed	134.5B USD	70	55	58	96	0 / 2
3	SanofiSNY · US-listed	108.6B USD	66	88	55	72	1 / 2
4	Intuitive Surgical, Inc.ISRG · US-listed	155.7B USD	64	47	73	94	1 / 2
5	AstraZeneca PLCAZN · US-listed	285.2B USD	63	66	64	86	1 / 2
⋯
15	UnitedHealth Group IncorporatedUNH · US-listed	363.0B USD	47	65	38	61	2 / 2
18	Abbott LaboratoriesABT · US-listed	189.3B USD	45	57	26	68	2 / 2
18	Pfizer Inc.PFE · US-listed	171.0B USD	45	66	14	68	2 / 2
20	Merck & Co., Inc.MRK · US-listed	356.9B USD	37	54	20	55	2 / 2
21	Gilead Sciences, Inc.GILD · US-listed	207.7B USD	18	8	26	30	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…